Annual Sales of Bimatoprost reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Ophthalmology

Currency : USD

2020 Revenue in Millions : 378

2019 Revenue in Millions : 0

Growth (%) : 100

Product Web Link

Corporate PDF

02 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Ophthalmology

Currency : USD

2021 Revenue in Millions : 579

2020 Revenue in Millions : 378

Growth (%) : 53

Product Web Link

Corporate PDF

03 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Ophthalmology

Currency : USD

2022 Revenue in Millions : 514

2021 Revenue in Millions : 579

Growth (%) : -11

Product Web Link

Corporate PDF

04 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Ophthalmology

Currency : USD

2023 Revenue in Millions : 432

2022 Revenue in Millions : 514

Growth (%) : -16

Product Web Link

Corporate PDF

05 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Ophthalmology

Currency : USD

2017 Revenue in Millions : 689

2016 Revenue in Millions : 688

Growth (%) : 0.1

Portfolio PDF

Product Web Link

Corporate PDF

06 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Ophthalmology

Currency : USD

2018 Revenue in Millions : 684

2017 Revenue in Millions : 689

Growth (%) : -1%

Portfolio PDF

Product Web Link

Corporate PDF

07 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Ophthalmology

Currency : USD

2016 Revenue in Millions : 688

2015 Revenue in Millions : 544

Growth (%) : 26

Portfolio PDF

Product Web Link

Corporate PDF

08 Brand Name : Latisse

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Hypotrichosis of Eyelashes

Currency : USD

2017 Revenue in Millions : 65

2016 Revenue in Millions : 86

Growth (%) : -25

Portfolio PDF

Product Web Link

Corporate PDF

09 Brand Name : Lumigan/Ganfort

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Ophthalmology

Currency : USD

2019 Revenue in Millions : 630

2018 Revenue in Millions : 684

Growth (%) : -8

Portfolio PDF

Product Web Link

Corporate PDF

10 Brand Name : Latisse

AAPS 2024

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Hypotrichosis of Eyelashes

Currency : USD

2016 Revenue in Millions : 86

2015 Revenue in Millions : 73

Growth (%) : 18

Portfolio PDF

Product Web Link